Dietary, non-microbial intervention to prevent Helicobacter pylori-associated gastric diseases

Annals of Translational Medicine

Volumn 3, Issue 9, 2015, Pages

  Han, Young Min ^a   Park, Jong Min ^a   Jeong, Migyeong ^a   Yoo, Jun Hwan ^a   Kim, Won Hee ^a   Shin, Seok Pyo ^a   Ko, Weon Jin ^a   Hahm, Ki Baik ^a  

^a CHA University   (South Korea)

Author keywords

Carcinogenesis; Gastritis; Helicobacter pylori (H. pylori); Prevention control; Rejuvenation

Indexed keywords

EID: 85015484256     PISSN: 23055839     EISSN: 23055847     Source Type: Journal    
DOI: 10.3978/j.issn.2305-5839.2015.03.50     Document Type: Review

References (55)

1. Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984;1:1311-5.
2. Hentschel E, Brandstatter G, Dragosics B, et al. Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer. N Engl J Med 1993;328:308-12.
3. Schistosomes, liver flukes and Helicobacter pylori. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 7-14 June 1994. IARC Monogr Eval Carcinog Risks Hum 1994;61:1-241.
4. Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001;345:784-9.
5. Fukase K, Kato M, Kikuchi S, et al. Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial. Lancet 2008;372:392-7.
6. Lee SY. Current progress toward eradicating Helicobacter pylori in East Asian countries: differences in the 2013 revised guidelines between China, Japan, and South Korea. World J Gastroenterol 2014;20:1493-502.
7. Sachs G, Scott DR. Helicobacter pylori: Eradication or Preservation. F1000 Med Rep 2012;4:7.
8. Shiotani A, Cen P, Graham DY. Eradication of gastric cancer is now both possible and practical. Semin Cancer Biol 2013;23:492-501.
9. Park S, Yeo M, Jin JH, et al. Inhibitory activities and attenuated expressions of 5-LOX with red ginseng in Helicobacter pylori-infected gastric epithelial cells. Dig Dis Sci 2007;52:973-82.
10. Liu CX, Xiao PG. Recent advances on ginseng research in China. J Ethnopharmacol 1992;36:27-38.
11. Shao ZH, Xie JT, Vanden Hoek TL, et al. Antioxidant effects of American ginseng berry extract in cardiomyocytes exposed to acute oxidant stress. Biochim Biophys Acta 2004;1670:165-71.
12. Bae EA, Han MJ, Baek NI, et al. In vitro anti-Helicobacter pylori activity of panaxytriol isolated from ginseng. Arch Pharm Res 2001;24:297-9.
13. Park EK, Choo MK, Han MJ, et al. Ginsenoside Rh1 possesses antiallergic and anti-inflammatory activities. Int Arch Allergy Immunol 2004;133:113-20.
14. Smolinski AT, Pestka JJ. Modulation of lipopolysaccharide-induced proinflammatory cytokine production in vitro and in vivo by the herbal constituents apigenin (chamomile), ginsenoside Rb(1) (ginseng) and parthenolide (feverfew). Food Chem Toxicol 2003;41:1381-90.
15. Belogortseva NI, Yoon JY, Kim KH. Inhibition of Helicobacter pylori hemagglutination by polysaccharide fractions from roots of Panax ginseng. Planta Med 2000;66:217-20.
16. Yoo SH, Jung HS, Sohn WS, et al. Volatile sulfur compounds as a predictor for esophagogastroduodenal mucosal injury. Gut Liver 2008;2:113-8.
17. Choi K, Lee S, Lee J, et al. Beneficial Effect of Korea Red Ginseng on Halitosis; Attenuation of H2S Induced Inflammatory Mediators and cystathionine γ-lyase Expression. J Ginseng Res 2009:367-77.
18. Jeong JH, Jeong HR, Jo YN, et al. Ameliorating effects of aged garlic extracts against Abeta-induced neurotoxicity and cognitive impairment. BMC Complement Altern Med 2013;13:268.
19. Rana SV, Pal R, Vaiphei K, et al. Garlic in health and disease. Nutr Res Rev 2011;24:60-71.
20. Guercio V, Galeone C, Turati F, et al. Gastric cancer and allium vegetable intake: a critical review of the experimental and epidemiologic evidence. Nutr Cancer 2014;66:757-73.
21. Lee SY, Shin YW, Hahm KB. Phytoceuticals: mighty but ignored weapons against Helicobacter pylori infection. J Dig Dis 2008;9:129-39.
22. Cañizares P, Gracia I, Gómez LA, et al. Optimization of Allium sativum solvent extraction for the inhibition of in vitro growth of Helicobacter pylori. Biotechnol Prog 2002;18:1227-32.
23. O'Gara EA, Maslin DJ, Nevill AM, et al. The effect of simulated gastric environments on the anti-Helicobacter activity of garlic oil. J Appl Microbiol 2008;104:1324-31.
24. O'Gara EA, Hill DJ, Maslin DJ. Activities of garlic oil, garlic powder, and their diallyl constituents against Helicobacter pylori. Appl Environ Microbiol 2000;66:2269-73.
25. Cañizares P, Gracia I, Gómez LA, et al. Allyl-thiosulfinates, the bacteriostatic compounds of garlic against Helicobacter pylori. Biotechnol Prog 2004;20:397-401.
26. Iimuro M, Shibata H, Kawamori T, et al. Suppressive effects of garlic extract on Helicobacter pylori-induced gastritis in Mongolian gerbils. Cancer Lett 2002;187:61-8.
27. Gail MH, You WC. A factorial trial including garlic supplements assesses effect in reducing precancerous gastric lesions. J Nutr 2006;136:813S-5S.
28. Gail MH, Pfeiffer RM, Brown LM, et al. Garlic, vitamin, and antibiotic treatment for Helicobacter pylori: a randomized factorial controlled trial. Helicobacter 2007;12:575-8.
29. Fani A, Fani I, Delavar M, et al. Combined garlic-omeprazole versus standard quadruple therapy for eradication of Helicobacter pylori infection. Indian J Gastroenterol 2007;26:145-6.
30. Zhang MJ, Spite M. Resolvins: anti-inflammatory and proresolving mediators derived from omega-3 polyunsaturated fatty acids. Annu Rev Nutr 2012;32:203-27.
31. Harris WS. Achieving optimal n-3 fatty acid status: the vegetarian's challenge. or not. Am J Clin Nutr 2014;100:449S-52S.
32. Serhan CN. Pro-resolving lipid mediators are leads for resolution physiology. Nature 2014;510:92-101.
33. Siddiqui RA, Harvey KA, Zaloga GP, et al. Modulation of lipid rafts by Omega-3 fatty acids in inflammation and cancer: implications for use of lipids during nutrition support. Nutr Clin Pract 2007;22:74-88.
34. Hutton ML, Kaparakis-Liaskos M, Turner L, et al. Helicobacter pylori exploits cholesterol-rich microdomains for induction of NF-kappaB-dependent responses and peptidoglycan delivery in epithelial cells. Infect Immun 2010;78:4523-31.
35. Correia M, Michel V, Matos AA, et al. Docosahexaenoic acid inhibits Helicobacter pylori growth in vitro and mice gastric mucosa colonization. PLoS One 2012;7:e35072.
36. Meier R, Wettstein A, Drewe J, et al. Fish oil (Eicosapen) is less effective than metronidazole, in combination with pantoprazole and clarithromycin, for Helicobacter pylori eradication. Aliment Pharmacol Ther 2001;15:851-5.
37. Kuriki K, Wakai K, Matsuo K, et al. Gastric cancer risk and erythrocyte composition of docosahexaenoic acid with anti-inflammatory effects. Cancer Epidemiol Biomarkers Prev 2007;16:2406-15.
38. Kim BG, Shin KS, Yoon TJ, et al. Fermentation of Korean red ginseng by Lactobacillus plantarum M-2 and its immunological activities. Appl Biochem Biotechnol 2011;165:1107-19.
39. Chiu YH, Lu YC, Ou CC, et al. Lactobacillus plantarum MYL26 induces endotoxin tolerance phenotype in Caco-2 cells. BMC Microbiol 2013;13:190.
40. Messier C, Epifano F, Genovese S, et al. Licorice and its potential beneficial effects in common oro-dental diseases. Oral Dis 2012;18:32-9.
41. Penner R, Fedorak RN, Madsen KL. Probiotics and nutraceuticals: non-medicinal treatments of gastrointestinal diseases. Curr Opin Pharmacol 2005;5:596-603.
42. Capurso G, Marignani M, Piciucchi M, et al. Probiotics and severe acute pancreatitis. J Clin Gastroenterol 2008;42 Suppl 3 Pt 1:S148-51.
43. Petrof EO, Kojima K, Ropeleski MJ, et al. Probiotics inhibit nuclear factor-kappaB and induce heat shock proteins in colonic epithelial cells through proteasome inhibition. Gastroenterology 2004;127:1474-87.
44. Kruis W, Fric P, Pokrotnieks J, et al. Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine. Gut 2004;53:1617-23.
45. Patel A, Shah N, Prajapati JB. Clinical appliance of probiotics in the treatment of Helicobacter pylori infection-A brief review. J Microbiol Immunol Infect 2014;47:429-37.
46. Kim MN, Kim N, Lee SH, et al. The effects of probiotics on PPI-triple therapy for Helicobacter pylori eradication. Helicobacter 2008;13:261-8.
47. Franceschi F, Cazzato A, Nista EC, et al. Role of probiotics in patients with Helicobacter pylori infection. Helicobacter 2007;12 Suppl 2:59-63.
48. Gotteland M, Brunser O, Cruchet S. Systematic review: are probiotics useful in controlling gastric colonization by Helicobacter pylori? Aliment Pharmacol Ther 2006;23:1077-86.
49. Ryan KA, O'Hara AM, van Pijkeren JP, et al. Lactobacillus salivarius modulates cytokine induction and virulence factor gene expression in Helicobacter pylori. J Med Microbiol 2009;58:996-1005.
50. Lee JS, Paek NS, Kwon OS, et al. Anti-inflammatory actions of probiotics through activating suppressor of cytokine signaling (SOCS) expression and signaling in Helicobacter pylori infection: a novel mechanism. J Gastroenterol Hepatol 2010;25:194-202.
51. Yang YJ, Chuang CC, Yang HB, et al. Lactobacillus acidophilus ameliorates H. pylori-induced gastric inflammation by inactivating the Smad7 and NFkappaB pathways. BMC Microbiol 2012;12:38.
52. Wilhelm SM, Johnson JL, Kale-Pradhan PB. Treating bugs with bugs: the role of probiotics as adjunctive therapy for Helicobacter pylori. Ann Pharmacother 2011;45:960-6.
53. Tong JL, Ran ZH, Shen J, et al. Meta-analysis: the effect of supplementation with probiotics on eradication rates and adverse events during Helicobacter pylori eradication therapy. Aliment Pharmacol Ther 2007;25:155-68.
54. Vítor JM, Vale FF. Alternative therapies for Helicobacter pylori: probiotics and phytomedicine. FEMS Immunol Med Microbiol 2011;63:153-64.
55. Bhatt A. Evolution of clinical research: a history before and beyond james lind. Perspect Clin Res 2010;1:6-10.